{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:23:58Z","timestamp":1775654638198,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T00:00:00Z","timestamp":1392768000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s11239-014-1061-x","type":"journal-article","created":{"date-parts":[[2014,2,18]],"date-time":"2014-02-18T11:48:52Z","timestamp":1392724132000},"page":"196-200","source":"Crossref","is-referenced-by-count":22,"title":["Recurrent thrombosis prevention with intravenous immunoglobulin and hydroxychloroquine during pregnancy in a patient with history of catastrophic antiphospholipid syndrome and pregnancy loss"],"prefix":"10.1007","volume":"38","author":[{"given":"Nataliya","family":"Mar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Kosowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Hook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,19]]},"reference":[{"issue":"10","key":"1061_CR1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","volume":"346","author":"JS Levine","year":"2002","unstructured":"Levine JS, Branch DW, Rauch J (2002) The antiphospholipid syndrome. N Engl J Med 346(10):752\u2013763","journal-title":"N Engl J Med"},{"issue":"9751","key":"1061_CR2","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","volume":"376","author":"G Ruiz-Irastorza","year":"2010","unstructured":"Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA (2010) Antiphospholipid syndrome. Lancet 376(9751):1498\u20131509","journal-title":"Lancet"},{"issue":"12","key":"1061_CR3","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/ajh.22157","volume":"86","author":"J Kujovich","year":"2011","unstructured":"Kujovich J, Merrill PA (2011) Antiphospholipid antibodies and antithrombin deficiency: double trouble for pregnancy. Am J Hematol 86(12):1028\u20131031","journal-title":"Am J Hematol"},{"issue":"2","key":"1061_CR4","first-page":"41","volume":"5","author":"FA Prima Di","year":"2011","unstructured":"Di Prima FA, Valenti O, Hyseni E, Giorgio E, Faraci M, Renda E et al (2011) Antiphospholipid syndrome during pregnancy: the state of the art. J Prenat Med 5(2):41\u201353","journal-title":"J Prenat Med"},{"issue":"1\u20132","key":"1061_CR5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000093565","volume":"35","author":"R Cervera","year":"2006","unstructured":"Cervera R, Asherton RA (2006) Catastrophic antiphospholipid syndrome. Pathophysiol Haemost Thromb 35(1\u20132):181\u2013186","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"7","key":"1061_CR6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","volume":"12","author":"RA Asherson","year":"2003","unstructured":"Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC (2003) Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12(7):530\u2013534","journal-title":"Lupus"},{"issue":"6","key":"1061_CR7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/ard.2006.061671","volume":"66","author":"JA G\u00f3mez-Puerta","year":"2007","unstructured":"G\u00f3mez-Puerta JA, Cervera R, Espinosa G, Asherson RA, Garc\u00eda-Carrasco M, da Costa IP et al (2007) Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases. Ann Rheum Dis 66(6):740\u2013746","journal-title":"Ann Rheum Dis"},{"issue":"2 Suppl","key":"1061_CR8","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","volume":"141","author":"SM Bates","year":"2012","unstructured":"Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO (2012) Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e691S\u2013e736S","journal-title":"Chest"},{"issue":"5","key":"1061_CR9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00124743-200110000-00017","volume":"7","author":"GR Hsiao","year":"2001","unstructured":"Hsiao GR, Wolf RE, Kimpel DL (2001) Intravenous immunoglobulin to prevent recurrent thrombosis in the antiphospholipid syndrome. J Clin Rheumatol 7(5):336\u2013339","journal-title":"J Clin Rheumatol"},{"issue":"4","key":"1061_CR10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/rheumatology\/39.4.421","volume":"39","author":"Y Sherer","year":"2000","unstructured":"Sherer Y, Levy Y, Shoenfeld Y (2000) Intravenous immunoglobulin therapy of antiphospholipid syndrome. Rheumatology (Oxford) 39(4):421\u2013426","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1061_CR11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3892\/etm.2012.743","volume":"5","author":"J Xiao","year":"2013","unstructured":"Xiao J, Xiong J, Zhu F, He L (2013) Effect of prednisone, aspirin, low molecular weight heparin and intravenous immunoglobulin on outcome of pregnancy in women with antiphospholipid syndrome. Exp Ther Med 5(1):287\u2013291","journal-title":"Exp Ther Med"},{"issue":"1 Pt 1","key":"1061_CR12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0002-9378(00)70500-X","volume":"182","author":"DW Branch","year":"2000","unstructured":"Branch DW, Peaceman AM, Druzin M, Silver RK, El-Sayed Y, Silver RM et al (2000) A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol 182(1 Pt 1):122\u2013127","journal-title":"Am J Obstet Gynecol"},{"key":"1061_CR13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1196\/annals.1361.118","volume":"1051","author":"T Sapir","year":"2005","unstructured":"Sapir T, Blank M, Shoenfeld Y (2005) Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss. Ann N Y Acad Sci 1051:743\u2013778","journal-title":"Ann N Y Acad Sci"},{"issue":"23 Suppl 1","key":"1061_CR14","first-page":"I9","volume":"107","author":"FA Anderson Jr","year":"2003","unstructured":"Anderson FA Jr, Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107(23 Suppl 1):I9\u2013I16","journal-title":"Circulation"},{"issue":"3","key":"1061_CR15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11239-009-0356-9","volume":"29","author":"R Diz-Kucukkaya","year":"2010","unstructured":"Diz-Kucukkaya R, Hancer VS, Artim-Esen B, Pekcelen Y, Inanc M (2010) The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome. J Thromb Thrombolysis 29(3):303\u2013309","journal-title":"J Thromb Thrombolysis"},{"key":"1061_CR16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0025-7125(16)30151-1","volume":"78","author":"RL Bick","year":"1994","unstructured":"Bick RL (1994) Hypercoagulability and thrombosis. Med Clin North Am 78:635\u2013665","journal-title":"Med Clin North Am"},{"issue":"11","key":"1061_CR17","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMra1112830","volume":"368","author":"B Giannakopoulos","year":"2013","unstructured":"Giannakopoulos B, Krilis SA (2013) The pathogenesis of the antiphospholipid syndrome. N Engl J Med 368(11):1033\u20131044","journal-title":"N Engl J Med"},{"issue":"3","key":"1061_CR18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1160\/TH06-05-0287","volume":"96","author":"A Ruffatti","year":"2006","unstructured":"Ruffatti A, Tonello M, Del Ross T, Cavazzana A, Grava C, Noventa F et al (2006) Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost 96(3):337\u2013341","journal-title":"Thromb Haemost"},{"issue":"1","key":"1061_CR19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semnephrol.2006.09.006","volume":"27","author":"MJ Fischer","year":"2007","unstructured":"Fischer MJ, Rauch J, Levine JS (2007) The antiphospholipid syndrome. Semin Nephrol 27(1):35\u201346","journal-title":"Semin Nephrol"},{"key":"1061_CR20","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/0002-9378(92)91596-3","volume":"166","author":"FS Cowchock","year":"1992","unstructured":"Cowchock FS, Reece EA, Baldan D et al (1992) Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low dose heparin treatment. Am J Obstet Gynecol 166:1318\u20131327","journal-title":"Am J Obstet Gynecol"},{"key":"1061_CR21","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2004.11.002","volume":"83","author":"LS Noble","year":"2005","unstructured":"Noble LS, Kutteh WH, Lashey N et al (2005) Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil Steril 83:684\u2013690","journal-title":"Fertil Steril"},{"key":"1061_CR22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1701-2163(16)30644-2","volume":"26","author":"MD Stephenson","year":"2004","unstructured":"Stephenson MD, Ballem PJ, Tsang P et al (2004) Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. J Obstet Gynaecol Can 26:729\u2013734","journal-title":"J Obstet Gynaecol Can"},{"key":"1061_CR23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-0897.1996.tb00501.x","volume":"35","author":"WH Kutteh","year":"1996","unstructured":"Kutteh WH, Ermel LD (1996) A clinical trial for the treatment of antiphospholipid-antibody associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol 35:402\u2013407","journal-title":"Am J Reprod Immunol"},{"issue":"11","key":"1061_CR24","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2009-04-213520","volume":"115","author":"JH Rand","year":"2010","unstructured":"Rand JH, Wu XX, Quinn AS, Ashton AW, Chen PP, Hathcock JJ et al (2010) Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug. Blood 115(11):2292\u20132299","journal-title":"Blood"},{"issue":"7","key":"1061_CR25","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1191\/0961203303lu393oa","volume":"12","author":"A Tincani","year":"2003","unstructured":"Tincani A, Branch W, Levy RA, Piette JC, Carp H, Rai RS et al (2003) Treatment of pregnant patients with antiphospholipid syndrome. Lupus 12(7):524\u2013529","journal-title":"Lupus"},{"issue":"4","key":"1061_CR26","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/1529-0131(200104)44:4<876::AID-ANR144>3.0.CO;2-2","volume":"44","author":"SS Pierangeli","year":"2001","unstructured":"Pierangeli SS, Espinola R, Liu X, Harris EN, Salmon JE (2001) Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype. Arthritis Rheum 44(4):876\u2013883","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"1061_CR27","first-page":"79","volume":"97","author":"C Duhem","year":"1994","unstructured":"Duhem C, Dicato MA, Ries F (1994) Side-effects of intravenous immune globulins. Clin Exp Immunol 97(Suppl 1):79\u201383","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"1061_CR28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.blre.2008.03.005","volume":"22","author":"I Uthman","year":"2008","unstructured":"Uthman I, Godeau B, Taher A, Khamashta M (2008) The hematologic manifestations of the antiphospholipid syndrome. Blood Rev 22(4):187\u2013194","journal-title":"Blood Rev"},{"issue":"6","key":"1061_CR29","first-page":"340","volume":"28","author":"M Persico","year":"1996","unstructured":"Persico M, Niglio A, Valentini G, Torella R (1996) Thrombocytopenia as a sensitive marker of immunologic activity in a patient with autoimmune chronic active hepatitis. Ital J Gastroenterol 28(6):340\u2013342","journal-title":"Ital J Gastroenterol"},{"issue":"5","key":"1061_CR30","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3109\/09537101003735564","volume":"21","author":"H Zhao","year":"2010","unstructured":"Zhao H, Li S, Yang R (2010) Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis. Platelets 21(5):380\u2013385","journal-title":"Platelets"},{"issue":"2","key":"1061_CR31","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ajh.21060","volume":"83","author":"JE Spahr","year":"2008","unstructured":"Spahr JE, Rodgers GM (2008) Treatment of immune-mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: a retrospective review of 40 patients. Am J Hematol 83(2):122\u2013125","journal-title":"Am J Hematol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-014-1061-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-014-1061-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-014-1061-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T14:54:35Z","timestamp":1565189675000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-014-1061-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,19]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["1061"],"URL":"https:\/\/doi.org\/10.1007\/s11239-014-1061-x","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,19]]}}}